Trials / Sponsors / HepNet Study House, German Liverfoundation
HepNet Study House, German Liverfoundation
Network · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection Acute Hepatitis C | Phase 2 | 2014-11-01 |
| Completed | The Hepatitis Delta International Network Hepatitis D | — | 2013-11-01 |
| Completed | Seasonal Flu Vaccine in Adult Transplant Recipients Immunocompromised, Transplanted | Phase 2 | 2010-11-01 |
| Terminated | H1N1sw Vaccine in Adult Transplant Recipients Immunocompromised | Phase 2 | 2010-02-01 |
| Completed | HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis Hepatitis D | Phase 2 | 2009-06-01 |
| Terminated | Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients Hepatitis C, Chronic | Phase 4 | 2008-11-01 |
| Completed | Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir Liver Transplantation, Hepatitis B, Liver Disease | Phase 3 | 2008-03-01 |